Coronary Artery Occlusion
8
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Impact of a Corrie Cardiac Rehabilitation Program
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Absorb GT1 Japan PMS
XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)
IVUS Analysis for Coronary Obstruction in TAVI
Neuroaxial Prophylaxis for CABG
Effects of Respiratory Muscle Training on Postoperative Pulmonary Complications of Cardiac Surgery
Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery